Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588634 · ClinicalTrials.gov registry record · NA
The PERSEVERE Study
A NA study of Pulmonary Embolism and Pulmonary Thromboembolism, sponsored by Inari Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 20
- Study locations
NCT06588634 is a NA study of Pulmonary Embolism and Pulmonary Thromboembolism that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 200 participants, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT06588634, a NA study of Pulmonary Embolism and Pulmonary Thromboembolism, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
Conditions Studied
Interventions
- PROCEDURE Standard of Care
- DEVICE FlowTriever System
Study Locations (20)
Other
- Besançon University Hospital - Besançon
- Hopital Arnaud de Villeneuve, Montpellier - Montpellier
- CHU Nîmes Caremeau - Nîmes
- Hôpital Européen Georges-Pompidou, Paris - Paris
- Klinikum Chemnitz - Chemnitz
- Universitätsklinikum Carl Gustav Carus an der TU Dresden - Dresden
- Universitätsmedizin Mainz - Mainz
- Munich LMU - München
Florida
- Orlando Health Regional Medical Center - Orlando
- Sarasota Memorial Hospital - Sarasota
New York
- Northwell Health - Bay Shore
- SUNY, The University at Buffalo - Buffalo
Pennsylvania
- UPHS Penn Health System - Philadelphia
- Allegheny General Hospital - Pittsburgh
Texas
- HCA Medical City Heart & Spine - Dallas
- HCA Methodist Health San Antonio - San Antonio
Connecticut
- Yale University - New Haven
Georgia
- Emory University - Atlanta
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06588634
The ClinicalTrials.gov registry entry for NCT06588634 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,054-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (93% lower). The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06588634 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06588634 about?
NCT06588634 is a clinical study titled "The PERSEVERE Study". Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
What is the current status of trial NCT06588634?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-12-16. Estimated completion is 2027-08-31.
What conditions does trial NCT06588634 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Pulmonary Thromboembolism.
What interventions are being tested in trial NCT06588634?
The interventions under investigation include: Standard of Care (PROCEDURE), FlowTriever System (DEVICE).
Who is sponsoring clinical trial NCT06588634?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588634 being conducted?
This trial has 20 study locations across Connecticut, Florida, Georgia, Mississippi, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.